Vice President, Access, Value Evidence & Pricing

The Vice President, Access, Value Evidence & Pricing leads the global value, pricing, reimbursement, evidence, and patient access strategy for Rocket Pharma's gene therapy portfolio. Reporting to the Chief Commercialization Officer, this role builds and directs an integrated function spanning U.S. and international market access, HEOR, and patient services. The position ensures sustainable patient access and commercial viability by developing enterprise-level strategies, managing payer relationships, and shaping access policy.